Nakashima, S. et al. 2012. Development of imatinibmesylate-induced interstitial lung disease 2 weeks after discontinuation of the treatment: a case report. Multidisciplinary Respiratory Medicine. 7, (Nov. 2012). DOI:https://doi.org/10.4081/mrm.2012.635.